piracetam has been researched along with Deficiency, Mental in 24 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the efficacy and safety of levetiracetam in adults with intellectual disabilities who have uncontrolled partial or generalised epilepsy." | 9.14 | A prospective multi-centre open label study of the use of levetiracetam as add-on treatment in patients with epilepsy and intellectual disabilities. ( Beavis, J; Felce, D; Kerr, M; Meek, A, 2009) |
| "Piracetam is widely used as a purported means of improving cognitive function in children with Down syndrome." | 9.09 | Piracetam therapy does not enhance cognitive functioning in children with down syndrome. ( Bryson, S; Greenbaum, R; Haslam, RH; Karaskov, V; Koren, G; Lobaugh, NJ; Rombough, V; Rovet, J, 2001) |
| "With the diagnosis of Lennox-Gastaut syndrome the patient was treated with levetiracetam, showing a substantial improvement in the cognitive sphere, in the control of seizures, and electroencephalographic findings." | 7.77 | Levetiracetam efficacy in patients with Lennox-Gastaut syndrome. Presentation of a case. ( Carneado Ruiz, J; Díaz Negrillo, A; González Salaices, M; Martín Del Valle, F; Prieto Jurczynska, C, 2011) |
| "In this retrospective study of institutionalized patients with mental retardation, we present the efficacy and safety of sequential treatment with intrarectal diazepam (IRD) gel (Diastat) and intravenous levetiracetam (IVL) in comparison with either treatment alone for acute repetitive or prolonged seizures (ARPS)." | 7.76 | Sequential intrarectal diazepam and intravenous levetiracetam in treating acute repetitive and prolonged seizures. ( Milteer, WE; Modur, PN; Zhang, S, 2010) |
| "To evaluate the efficacy and tolerability of levetiracetam in children with drug resistant epilepsy from a retrospective study." | 7.73 | [Experience with levetiracetam in childhood epilepsy]. ( Fogarasi, A; Hegyi, M; Herczegfalvi, A; Kollár, K; Móser, J; Neuwirth, M; Paraicz, E; Rosdy, B; Saracz, J, 2006) |
| "Levetiracetam (LEV) is a novel antiepileptic drug (AED) with efficacy against a wide range of seizures types." | 6.71 | Levetiracetam for people with mental retardation and refractory epilepsy. ( Brodie, MJ; Kelly, K; Stephen, LJ, 2004) |
| "Lennox-Gastaut syndrome is an epileptic encephalopathy characterized by multiple seizure types, mental retardation, and a slow spike-and-wave pattern on electroencephalography." | 5.32 | Levetiracetam in the treatment of Lennox-Gastaut syndrome. ( De Los Reyes, EC; Hale, SE; Sharp, GB; Williams, JP, 2004) |
| "To investigate the efficacy and safety of levetiracetam in adults with intellectual disabilities who have uncontrolled partial or generalised epilepsy." | 5.14 | A prospective multi-centre open label study of the use of levetiracetam as add-on treatment in patients with epilepsy and intellectual disabilities. ( Beavis, J; Felce, D; Kerr, M; Meek, A, 2009) |
| "Piracetam is widely used as a purported means of improving cognitive function in children with Down syndrome." | 5.09 | Piracetam therapy does not enhance cognitive functioning in children with down syndrome. ( Bryson, S; Greenbaum, R; Haslam, RH; Karaskov, V; Koren, G; Lobaugh, NJ; Rombough, V; Rovet, J, 2001) |
| "On pharmacological treatment of epilepsy in people with intellectual disabilities, there were two articles on topiramate and one on levetiracetam." | 4.83 | Update on treatment of epilepsy in people with intellectual disabilities. ( Huber, B; Seidel, M, 2006) |
| "With the diagnosis of Lennox-Gastaut syndrome the patient was treated with levetiracetam, showing a substantial improvement in the cognitive sphere, in the control of seizures, and electroencephalographic findings." | 3.77 | Levetiracetam efficacy in patients with Lennox-Gastaut syndrome. Presentation of a case. ( Carneado Ruiz, J; Díaz Negrillo, A; González Salaices, M; Martín Del Valle, F; Prieto Jurczynska, C, 2011) |
| "In this retrospective study of institutionalized patients with mental retardation, we present the efficacy and safety of sequential treatment with intrarectal diazepam (IRD) gel (Diastat) and intravenous levetiracetam (IVL) in comparison with either treatment alone for acute repetitive or prolonged seizures (ARPS)." | 3.76 | Sequential intrarectal diazepam and intravenous levetiracetam in treating acute repetitive and prolonged seizures. ( Milteer, WE; Modur, PN; Zhang, S, 2010) |
| " We could not demonstrate any association between the paradoxical effect of levetiracetam and type of epilepsy or the antiepileptic comedication used." | 3.74 | The risk of paradoxical levetiracetam effect is increased in mentally retarded patients. ( Barcs, G; Clemens, Z; Fabó, D; Holló, A; Jakus, R; Janszky, J; Kelemen, A; Rásonyi, G; Szucs, A, 2008) |
| "To evaluate the efficacy and tolerability of levetiracetam in children with drug resistant epilepsy from a retrospective study." | 3.73 | [Experience with levetiracetam in childhood epilepsy]. ( Fogarasi, A; Hegyi, M; Herczegfalvi, A; Kollár, K; Móser, J; Neuwirth, M; Paraicz, E; Rosdy, B; Saracz, J, 2006) |
| "Levetiracetam (LEV) is a novel antiepileptic drug (AED) with efficacy against a wide range of seizures types." | 2.71 | Levetiracetam for people with mental retardation and refractory epilepsy. ( Brodie, MJ; Kelly, K; Stephen, LJ, 2004) |
| "Lennox-Gastaut syndrome is an epileptic encephalopathy characterized by multiple seizure types, mental retardation, and a slow spike-and-wave pattern on electroencephalography." | 1.32 | Levetiracetam in the treatment of Lennox-Gastaut syndrome. ( De Los Reyes, EC; Hale, SE; Sharp, GB; Williams, JP, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (29.17) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (50.00) | 29.6817 |
| 2010's | 5 (20.83) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bozkurt, H | 1 |
| Carpay, JA | 1 |
| Aalbers, K | 1 |
| Graveland, GA | 1 |
| Engelsman, M | 1 |
| Yang, Z | 1 |
| Liu, X | 1 |
| Qin, J | 1 |
| Zhang, Y | 1 |
| Bao, X | 1 |
| Xiong, H | 1 |
| Beavis, J | 1 |
| Meek, A | 1 |
| Felce, D | 1 |
| Kerr, M | 1 |
| Modur, PN | 1 |
| Milteer, WE | 1 |
| Zhang, S | 1 |
| Díaz Negrillo, A | 1 |
| Martín Del Valle, F | 1 |
| González Salaices, M | 1 |
| Prieto Jurczynska, C | 1 |
| Carneado Ruiz, J | 1 |
| Deriaz, N | 1 |
| Willi, JP | 1 |
| Orihuela-Flores, M | 1 |
| Galli Carminati, G | 1 |
| Ratib, O | 1 |
| Isoda, K | 1 |
| Tomoyasu, C | 1 |
| Fujii, N | 1 |
| Nishimura, A | 1 |
| De Los Reyes, EC | 1 |
| Sharp, GB | 1 |
| Williams, JP | 1 |
| Hale, SE | 1 |
| Brodtkorb, E | 1 |
| Klees, TM | 1 |
| Nakken, KO | 1 |
| Lossius, R | 1 |
| Johannessen, SI | 1 |
| Kelly, K | 1 |
| Stephen, LJ | 1 |
| Brodie, MJ | 1 |
| Hurtado, B | 1 |
| Koepp, MJ | 1 |
| Sander, JW | 1 |
| Thompson, PJ | 1 |
| Neuwirth, M | 1 |
| Saracz, J | 1 |
| Hegyi, M | 1 |
| Paraicz, E | 1 |
| Kollár, K | 1 |
| Móser, J | 1 |
| Rosdy, B | 1 |
| Herczegfalvi, A | 1 |
| Fogarasi, A | 1 |
| Huber, B | 1 |
| Seidel, M | 1 |
| Deb, S | 1 |
| Kaur Saini, ST | 1 |
| Szucs, A | 1 |
| Clemens, Z | 1 |
| Jakus, R | 1 |
| Rásonyi, G | 1 |
| Fabó, D | 1 |
| Holló, A | 1 |
| Barcs, G | 1 |
| Kelemen, A | 1 |
| Janszky, J | 1 |
| Gualtieri, CT | 1 |
| Golden, RN | 1 |
| Fahs, JJ | 1 |
| Turova, NF | 3 |
| Ermolina, LA | 3 |
| Baryshnikov, VA | 2 |
| Kopaladze, RA | 1 |
| Aziavchik, AV | 1 |
| Gorbachevskaia, NL | 1 |
| Avrutskaia, IG | 1 |
| Lobaugh, NJ | 1 |
| Karaskov, V | 1 |
| Rombough, V | 1 |
| Rovet, J | 1 |
| Bryson, S | 1 |
| Greenbaum, R | 1 |
| Haslam, RH | 1 |
| Koren, G | 1 |
| Houillon, P | 1 |
| Kitenge, A | 1 |
| Jouannigot, R | 1 |
| Lullien, L | 1 |
| Cadic, F | 1 |
| Misionzhnik, EIu | 1 |
| Kogan, RD | 1 |
| Balandina, IuB | 1 |
| Sazonova, NS | 1 |
2 reviews available for piracetam and Deficiency, Mental
| Article | Year |
|---|---|
Update on treatment of epilepsy in people with intellectual disabilities.
Topics: Anticonvulsants; Brain; Electric Stimulation Therapy; Epilepsy; Fructose; Humans; Intellectual Disab | 2006 |
New developments in pediatric psychopharmacology.
Topics: Adolescent; Adult; Aggression; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Autistic Disorder | 1983 |
4 trials available for piracetam and Deficiency, Mental
| Article | Year |
|---|---|
A prospective multi-centre open label study of the use of levetiracetam as add-on treatment in patients with epilepsy and intellectual disabilities.
Topics: Adult; Aged; Anticonvulsants; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Humans | 2009 |
Levetiracetam for people with mental retardation and refractory epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Behavior; Child; Drug Administration Schedule; Drug Evalua | 2004 |
New developments in pediatric psychopharmacology.
Topics: Adolescent; Adult; Aggression; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Autistic Disorder | 1983 |
Piracetam therapy does not enhance cognitive functioning in children with down syndrome.
Topics: Adolescent; Analysis of Variance; Child; Cognition; Cross-Over Studies; Double-Blind Method; Down Sy | 2001 |
19 other studies available for piracetam and Deficiency, Mental
| Article | Year |
|---|---|
Piracetam for Sialorrhea in 2 Children With Intellectual Disability.
Topics: Child, Preschool; Humans; Intellectual Disability; Male; Nootropic Agents; Piracetam; Sialorrhea; Tr | 2015 |
Retention of new AEDs in institutionalized intellectually disabled patients with epilepsy.
Topics: Adolescent; Adult; Amines; Anticonvulsants; Child; Cyclohexanecarboxylic Acids; Drug Utilization Rev | 2009 |
Partial seizures and atypical absence seizures as a single ictal event in a patient with Lennox-Gastaut syndrome.
Topics: Adolescent; Epilepsy; Epilepsy, Absence; Humans; Intellectual Disability; Levetiracetam; Male; Pirac | 2008 |
Sequential intrarectal diazepam and intravenous levetiracetam in treating acute repetitive and prolonged seizures.
Topics: Acute Disease; Administration, Rectal; Adult; Aged; Diazepam; Drug Therapy, Combination; Female; Hum | 2010 |
Levetiracetam efficacy in patients with Lennox-Gastaut syndrome. Presentation of a case.
Topics: Anticonvulsants; Child, Preschool; Humans; Intellectual Disability; Lennox Gastaut Syndrome; Levetir | 2011 |
Treatment with levetiracetam in a patient with pervasive developmental disorders, severe intellectual disability, self-injurious behavior, and seizures: a case report.
Topics: Anticonvulsants; Child; Child Development Disorders, Pervasive; Humans; Intellectual Disability; Lev | 2012 |
[Levetiracetam-induced aggravation to non-convulsive status epilepticus in a boy with Lennox-Gastaut syndrome].
Topics: Anticonvulsants; Child; Humans; Intellectual Disability; Lennox Gastaut Syndrome; Levetiracetam; Mal | 2012 |
Levetiracetam in the treatment of Lennox-Gastaut syndrome.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy, Generaliz | 2004 |
Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Dose-Response Relationship, Drug; Drug Resistance; Drug Th | 2004 |
The impact of levetiracetam on challenging behavior.
Topics: Adult; Anticonvulsants; Behavior; Epilepsy; Female; Humans; Intellectual Disability; Levetiracetam; | 2006 |
[Experience with levetiracetam in childhood epilepsy].
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Child; Child, Preschool; Epilepsy; Female; Humans; | 2006 |
Levetiracetam for the treatment of epilepsy among adults with intellectual disabilities.
Topics: Adolescent; Adult; Anticonvulsants; Epilepsy; Female; Humans; Intellectual Disability; Levetiracetam | 2007 |
The risk of paradoxical levetiracetam effect is increased in mentally retarded patients.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Child; Disorders of Excessive Somnolence; Dizziness; Drug | 2008 |
[Effect of nootropic agents on serum biochemical indices in intellectually deficient children].
Topics: Cerebral Cortex; Child; Female; Fetal Hypoxia; Humans; Hypoxia, Brain; Intellectual Disability; Isoe | 1983 |
[Correlations between biological and clinical indices in children with intellectual deficiencies].
Topics: Amino Acids; Child; Electroencephalography; Female; Humans; Intellectual Disability; Male; Piracetam | 1982 |
[Selective action of metabolic drug therapy in mentally retarded children].
Topics: Child; gamma-Aminobutyric Acid; Humans; Intellectual Disability; Pantothenic Acid; Piracetam; Pyrith | 1980 |
[Use of metabolically active preparations to study mild forms of mental deficiency].
Topics: Child; Diagnosis, Differential; Female; gamma-Aminobutyric Acid; Humans; Intellectual Disability; Ma | 1980 |
[Various therapeutic effects of piracetam (1st part)].
Topics: Aged; Animals; Dementia; Female; Humans; Intellectual Disability; Piracetam; Pyrrolidinones | 1979 |
[Clinico-pathogenetic correlations in intellectual deficiency in premature infants].
Topics: Autoantibodies; Brain; Catecholamines; Child; Homovanillic Acid; Humans; Infant, Newborn; Infant, Pr | 1985 |